Technology is defined by GE Healthcare as:

• Pre-IND compounds requiring further pre-clinical development
• Sponsored Research Agreements
• Freedom-to-Practice License Agreements
• Non-product License Option Agreements
• Other non-product technology licensing deals

Technologies of Interest

• Ligands targeting specific disease related receptors in:
  • Cardiology
  • Oncology
  • Neurology
  • Internal Medicine (all others)
• Novel PET and SPECT Agents
• Novel MRI Agents
• Novel Ultrasound Agents
• Novel X-Ray Agents
• PET Chemistry
• Novel Imaging Modalities, e.g., Optical

Diseases of Interest

• CHF
• Coronary Artery Disease
• Vulnerable Plaque
• Stroke
• Alzheimer's Disease
• Parkinson's Disease
• Mood Disorders
• Cancer
  • Lung
  • CRC
  • Gastric
  • Bladder
  • Prostate
  • Breast
• Endometriosis
• COPD
• Pulmonary Embolism
• Inflammation